Karnataka HC: Caste Slurs at Factory Dispatch Area Accessible to Workers Amount to Public View  ||  Delhi HC: Lawyer’s Inability to Understand Lower Court Order Cannot Justify Delay in Filing Appeal  ||  Delhi HC: POCSO Charges Stay Even If Minors Remain Unidentified In Child Sexual Exploitation Cases  ||  J&K&L HC: Mere Abuse or Mentioning Caste Name Does Not Constitute an Offence under SC/ST Act  ||  Tripura HC: Divorced Daughter Cannot Claim Family Pension if Divorce Happens After Parent’s Death  ||  SC: Candidate Missing Physical Test Gets No Second Chance; Compassion Has No Place in Public Jobs  ||  SC Grants Bail to Doctors as Were Not Provided in Writing, Citing 'Mihir Shah' Verdict  ||  Supreme Court: Dowry Harassment and Domestic Abuse Persist, Showing Patriarchy Still Prevails  ||  Supreme Court: Dowry Harassment and Domestic Abuse Persist, Showing Patriarchy Still Prevails  ||  Supreme Court: Pay Commission Benefits Cannot Be Denied By Imposing Extra Conditions    

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - (22 Dec 2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.

Tags : GLENMARK PHARMACEUTICALS INC   FOREST LABORATORIES   LLC   FOREST LABORATORIES HOLDINGS     ROYALTY PHARMA COLLECTION TRUST  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved